Groww Logo
Home>US Stocks>Seattle Genetics Inc

Seattle Genetics Inc

Healthcare
$136.47
+ $3.00 (2.25%) 1D
1D
1W
1M
1Y
3Y
5Y

Performance

Today’s Low
$
    Today’s High
    $
    52W Low
    $
      52W High
      $
      Open PricePrev. CloseVolumeAvg. Volume
      $133.85$133.471,199,2711,161,369

      Fundamentals

      Market Cap$25.12B
      P/B Ratio8.4
      P/E Ratio-36.4
      Enterprise Value$24.91B
      Div. Yield0.00%
      Book Value16.33
      EPS(TTM)-0.74
      ROENA
      Understand Fundamentals

      About the Company

      Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company markets ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgki
      Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company markets ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; and PADCEV, an ADC composed of an anti-Nectin-4 monoclonal antibody for the treatment of metastatic urothelial cancers. It also develops Tucatinib, an investigational oral, small molecule TKI for HER2, a growth factor receptor; and Tisotumab Vedotin, an ADC composed of a human antibody that binds to tissue factor to treat various solid tumors, including cervical, ovarian, prostate, and bladder. In addition, the company develops ladiratuzumab vedotin, an ADC targeting LIV-1 and metastatic triple-negative breast cancer; SEA-BCMA, a clinical-stage non-fucosylated BCMA-directed antibody for patients with relapsed or refractory multiple myeloma. Seagen Inc. has collaboration agreements with Takeda Pharmaceutical Company Limited; Agensys, Inc.; Genmab A/S; biotechnology and pharmaceutical companies; and Merck. The company was formerly known as Seattle Genetics, Inc. and changed its name to Seagen Inc. in October 2020. Seagen Inc. was incorporated in 1997 and is headquartered in Bothell, Washington.
      ...Read more
      OrganisationSeattle Genetics Inc
      IndustryBiotechnology
      HeadQuartersBothell, WA

      Company Financials

      *All values are in Million $
      No Graph Data To Display
      Quarterly
      Yearly
      See Details

      FAQs on Seattle Genetics Inc

      Can I Buy Seattle Genetics Inc Shares in India?

      Yes, Seattle Genetics Inc shares can be bought in India by opening an international trading account with Groww.

      How to Buy Seattle Genetics Inc Shares in India?

      One can easily invest in Seattle Genetics Inc shares from India by: Direct Investment - Opening an international trading account with Groww which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Seattle Genetics Inc shares. Indirect Investment - Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Seattle Genetics Inc.

      What is the Share Price of Seattle Genetics Inc?

      The share price of Seattle Genetics Inc is in Dollars and if you are investing from India, you can always check the INR valuation before investing. The current Seattle Genetics Inc share price is $136.47 as of 25 May ‘22

      What is the Market Cap of Seattle Genetics Inc?

      The Seattle Genetics Inc market cap is $25.12B as of 25 May ‘22

      What is the PE and PB ratio of Seattle Genetics Inc?

      The PE and PB ratio of Seattle Genetics Inc is -36.4 and 8.4 as of 25 May ‘22
      ⓒ 2016-2022 Groww. All rights reserved, Built with in India
      MOST POPULAR ON GROWWVERSION - 2.4.0
      STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
      MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI

      ABOUT GROWW